Jeffrey Dierks Harmony Biosciences Holdings, Inc. (HRMY) insider trading activity

Jeffrey Dierks is CHIEF COMMERCIAL OFFICER of Harmony Biosciences Holdings, Inc.. Currently has a direct ownership of 0 shares of HRMY, which is worth approximately $0. The most recent transaction as insider was on Sep 30, 2024, when has been sold 35,846 shares (Common Stock) at a price of $40.03 per share, resulting in proceeds of $1,434,915. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Jeffrey Dierks Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2024	SELL Open market or private sale	$1,434,915 $40.03 p/Share	35,846 Reduced 100.0%	0 Common Stock
Sep 30 2024	BUY Exercise of conversion of derivative security	$860,304 $24.0 p/Share	35,846 Added 50.0%	35,846 Common Stock
Sep 27 2024	SELL Open market or private sale	$8,009 $40.05 p/Share	200 Reduced 100.0%	0 Common Stock
Sep 27 2024	BUY Exercise of conversion of derivative security	$4,800 $24.0 p/Share	200 Added 50.0%	200 Common Stock
Mar 15 2024	SELL Open market or private sale	$383,328 $32.0 p/Share	11,979 Reduced 100.0%	0 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	$98,467 $8.22 p/Share	11,979 Added 50.0%	11,979 Common Stock
Mar 08 2024	SELL Open market or private sale	$6,208 $32.0 p/Share	194 Reduced 100.0%	0 Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	$1,594 $8.22 p/Share	194 Added 50.0%	194 Common Stock
Oct 03 2022	SELL Open market or private sale	$547,298 $44.96 p/Share	12,173 Reduced 100.0%	0 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$100,062 $8.22 p/Share	12,173 Added 50.0%	12,173 Common Stock
Aug 22 2022	SELL Open market or private sale	$1,369,169 $47.26 p/Share	28,971 Reduced 100.0%	0 Common Stock
Aug 22 2022	BUY Exercise of conversion of derivative security	$695,304 $24.0 p/Share	28,971 Added 50.0%	28,971 Common Stock
Apr 01 2022	SELL Open market or private sale	$718,051 $49.62 p/Share	14,471 Reduced 100.0%	0 Common Stock
Apr 01 2022	BUY Exercise of conversion of derivative security	$347,304 $24.0 p/Share	14,471 Added 50.0%	14,471 Common Stock
Mar 01 2022	SELL Open market or private sale	$194,955 $40.04 p/Share	4,869 Reduced 100.0%	0 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$40,023 $8.22 p/Share	4,869 Added 50.0%	4,869 Common Stock
Feb 28 2022	SELL Open market or private sale	$401,640 $40.0 p/Share	10,041 Reduced 100.0%	0 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	$240,984 $24.0 p/Share	10,041 Added 50.0%	10,041 Common Stock
Feb 17 2022	SELL Open market or private sale	$170,445 $40.02 p/Share	4,259 Reduced 100.0%	0 Common Stock
Feb 17 2022	BUY Exercise of conversion of derivative security	$4,800 $24.0 p/Share	200 Added 50.0%	200 Common Stock
Feb 16 2022	SELL Open market or private sale	$170,573 $40.05 p/Share	4,259 Reduced 100.0%	0 Common Stock
Feb 16 2022	BUY Exercise of conversion of derivative security	$102,216 $24.0 p/Share	4,259 Added 50.0%	4,259 Common Stock
Jan 06 2022	SELL Open market or private sale	$247,756 $40.45 p/Share	6,125 Reduced 100.0%	0 Common Stock
Jan 06 2022	BUY Exercise of conversion of derivative security	$50,348 $8.22 p/Share	6,125 Added 50.0%	6,125 Common Stock
Nov 01 2021	SELL Open market or private sale	$419,000 $41.9 p/Share	10,000 Reduced 100.0%	0 Common Stock

Jeffrey Dierks

CHIEF COMMERCIAL OFFICER

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRMY shares.

Notify only if

Value

Insider Trading

Get notified when an Harmony Biosciences Holdings, Inc. insider buys or sells HRMY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Harmony Biosciences Holdings, Inc.

Track Activities on HRMY

Account